Clinical Trials Browser

Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Bortezomib × 90 days × Clear all

NCT00720785 2026-05-07

Natural Killer Cells and Bortezomib to Treat Cancer

LymphoidMyeloidOther hematologic neoplasmPlasma cellThoracic

Carcinoma, Non-Small-Cell Lung, Multiple Myeloma, Neoplasm Metastasis, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive